BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nissen LHC, Pierik M, Derikx LAAP, de Jong E, Kievit W, van den Heuvel TRA, van Rosendael AR, Plasmeijer EI, Dewint P, Verhoeven RHA, Overbeek LIH, Nagtegaal ID, Hoentjen F, van der Meulen–de Jong AE. Risk Factors and Clinical Outcomes in Patients with IBD with Melanoma: . Inflammatory Bowel Diseases 2017;23:2018-26. [DOI: 10.1097/mib.0000000000001191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Harper J. Health Maintenance in Patients with Ulcerative Colitis. Gastroenterology Clinics of North America 2020;49:809-20. [DOI: 10.1016/j.gtc.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Sebastian S, Neilaj S. Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment? Therap Adv Gastroenterol 2019;12:1756284818817293. [PMID: 30643542 DOI: 10.1177/1756284818817293] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
3 Hu X, Yuan L, Ma T. Mechanisms of JAK-STAT signaling pathway mediated by CXCL8 gene silencing on epithelial-mesenchymal transition of human cutaneous melanoma cells. Oncol Lett 2020;20:1973-81. [PMID: 32724443 DOI: 10.3892/ol.2020.11706] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cozzi S, Escarpa AS, Parra DL, Jamal DN, Mitjana JMC, R JMP, Edo FG, Miguelez CG. Association between inflammatory bowel disease and uveal melanoma: case report of two young adults and a literature review. Rep Pract Oncol Radiother 2019;24:56-9. [PMID: 30455614 DOI: 10.1016/j.rpor.2018.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Mala A, Foteinogiannopoulou K, Koutroubakis IE. Solid extraintestinal malignancies in patients with inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(12): 1956-1980 [DOI: 10.4251/wjgo.v13.i12.1956] [Reference Citation Analysis]
6 van de Ven SEM, Derikx LAAP, Nagtegaal ID, van Herpen CM, Takes RP, Melchers WJG, Pierik M, van den Heuvel T, Verhoeven RHA, Hoentjen F, Nissen LHC. Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk Factors. Inflamm Bowel Dis 2020;26:1060-7. [PMID: 31559415 DOI: 10.1093/ibd/izz210] [Reference Citation Analysis]
7 Cushing KC, Du X, Chen Y, Stetson LC, Kuppa A, Chen VL, Kahlenberg JM, Gudjonsson JE, Vanderwerff B, Higgins PDR, Speliotes EK. Inflammatory Bowel Disease Risk Variants Are Associated with an Increased Risk of Skin Cancer. Inflamm Bowel Dis 2022:izab336. [PMID: 35018451 DOI: 10.1093/ibd/izab336] [Reference Citation Analysis]